The study identifies an opportunity to discover a PKA-independent pathway downstream of oncogene GNAS for managing IPMN lesions and their progression to PDAC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10906748 | PMC |
| http://dx.doi.org/10.1158/1541-7786.MCR-23-0199 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Application of 9-gene panel in assisting fine needle aspiration cytology to diagnose thyroid cancer].
Zhonghua Zhong Liu Za Zhi
November 2024
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.
Article Synopsis
- The study investigates the effectiveness of a 9-gene panel for diagnosing thyroid nodules that have indeterminate cytological results, compared to traditional BRAF V600E single-gene detection.
- Researchers analyzed 579 thyroid nodule samples from patients, using next-generation sequencing to identify mutations in nine specific genes associated with cancer.
- The results showed that 47.5% of tested nodules had mutations, with a majority of identified malignant cases linked to the BRAF gene, demonstrating the panel's potential as a diagnostic tool alongside standard cytology methods.
Next-generation sequencing improves diagnostic accuracy of imaging and carcinoembryonic antigen alone for pancreatic cystic neoplasms.
Pancreatology
December 2024
Abdominal Center, Department of Gastrointestinal Surgery, Helsinki University Hospital and Helsinki University, Finland.
Background: New tools are needed to determine the pancreatic cysts that require surgical resection. This study aimed to evaluate whether next-generation sequencing (NGS) is useful for identifying mucinous, malignant, or pre-malignant cysts leading to surgery.
Methods: Laboratory, cytological, and histological data from 97 patients with worrisome features on imaging or an unclear pancreatic cystic lesion (PCL) who were indicated for further investigation and who underwent endoscopic ultrasound (EUS) and fine-needle aspiration (FNA) between 2018 and 2022 were analyzed.
Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.
Cancer Med
October 2024
Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Background And Aim: Pseudomyxoma peritonei (PMP) is an unusual condition with unique behaviour caused by a mucinous neoplasm, usually arising from the appendix. The aim of this study was to evaluate the prevalence of genomic alterations in clinical specimens of PMP using a targeted assay and correlate the findings with clinical, pathological and outcome data. Sequencing data from 223 patients were analysed.
View Article and Find Full Text PDFCyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.
J Clin Oncol
October 2024
Department of Surgery, University of California, San Diego, La Jolla, CA.
Article Synopsis
- Mucinous neoplasms of the gastrointestinal tract, particularly from the appendix, are known to spread to the peritoneum, resulting in poor treatment outcomes and low response rates to traditional chemotherapy, prompting research into alternative therapies.* -
- A study involving 16 patients with peritoneal mucinous carcinomatosis examined the efficacy of palbociclib, a CDK4/6 inhibitor, which showed a significant decrease in tumor markers and stable disease in 50% of patients after 12 months.* -
- The findings suggest that palbociclib may offer a better clinical response for patients with mutations in the targeted oncogene compared to conventional cytotoxic treatments, indicating potential for further research in this area
Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN).
Genes Chromosomes Cancer
October 2024
Comprehensive Cancer Center Mainfranken, University of Würzburg Medical Centre, Würzburg, Germany.
Low-grade appendiceal mucinous neoplasia (LAMN) represents a relatively rare tumor of the appendix typically diagnosed incidentally through appendectomy for acute appendicitis. In cases where perforation occurs, mucinous content may disseminate into the abdominal cavity, leading to the development of pseudomyxoma peritonei (PMP). The primary objective of this study was to elucidate the molecular characteristics associated with various stages of LAMN and PMP.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!